This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Analysts' Actions: ADTN CMI COG DRI MSFT

Stocks in this article: ADTNCMICOGDRILMCAMSFT

Supernus Pharmaceuticals (SUPN) was initiated with a buy rating at Lazard. $16 price target. New epilepsy drugs should drive growth, Lazard said.

Tibco (TIBX) was downgraded at Bank of America/Merrill Lynch from buy to neutral. $26 price target. Company is seeing lower results across the board, BofA/Merrill said.

WABCO (WBC) was downgraded at William Blair to market perform from outperform. Valuation call and potential downward EPS revisions, Blair said. $65 price target.

Wesco (WCC) was downgraded at FBR Capital Markets from outperform to market perform. $66 price target. Stock also cut from Top Picks list. Lower organic growth may cut into margins over the coming quarters, FBR Capital Markets said.

Whitewave Foods (WWAV) was initiated with a buy rating at Bank of America/Merrill Lynch. $18 price target. Company can grow twice as fast as its peers, BofA/Merrill said.

STOCK COMMENTS / EPS CHANGES

Altera Corp (ALTR) numbers lowered at Jefferies. Shares of ALTR now seen reaching $35, Jefferies said. Estimates also lowered on mid- quarter update. Hold rating.

Darden Restaurants (DRI) numbers cut at UBS. Shares of DRI now seen reaching $52, UBS said. Estimates also lowered on negative F2Q preannouncement. Buy rating.

Baker Hughes (BHI) estimates reduced at Guggenheim through 2013, Guggenheim said. Company is seeing slower international demand. Neutral rating and $50 price target.

Edwards Lifesciences (EW) numbers raised at Citigroup. Shares of EW now seen reaching $98, Citigroup said. Estimates also increased on greater US TAVI revenues. Neutral rating.

Coca-Cola (KO) estimates lowered at JP Morgan through 2013, JP Morgan said. Company is leveraged to slower international growth. Neutral rating and $43 price target.

Mattress Firm (MFRM) numbers cut at Keybanc. MFRM estimates were reduced through 2013, Keybanc said. Company is facing increased competition. Buy rating and new $34 price target.

Microsoft (MSFT) estimates, target cut at MKM. Shares of MSFT now seen reaching $28, according to MKM Partners. Estimates also reduced, as recent checks show lower demand for Windows 8 Surface.

Vail Resorts (MTN) numbers reduced at JMP. MTN estimates were cut through 2013, JMP Securities said. Company has had a slow start to its season. Outperform rating and new $60 price target.

Regal Beloit (RBC) numbers boosted at JMP. Shares of RBC now seen reaching $78, according to JMP Securities. Estimates also upped, as new products should help drive growth over the coming quarters. Outperform rating.

AT&T (T) estimates trimmed at Citigroup through 2013, Citigroup said. Accelerated network investments. $39 price target and Buy rating.

TIBCO Software (TIBX) numbers lowered at Jefferies. Shares of TIBX now seen reaching $25, Jefferies said. Estimates also lowered on weakness throughout BI/data analytics. Buy rating.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.
2 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,705.90 +244.58 1.49%
S&P 500 1,955.40 +28.29 1.47%
NASDAQ 4,461.1240 +78.2770 1.79%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs